Results of endoscopic treatment of benign prostatic hyperplasia in patients with metabolic syndrome
Keywords:
holmium enucleation, intraoperative blood loss, metabolic syndrome, prostatic hyperplasia, transurethral resectionAbstract
The present paper is about the research conducted on the patients with metabolic syndrome and its results of endoscopic treatment of benign prostatic hyperplasia in these patients. It is generally accepted that the size and volume of the prostate gland is the main prognostic factor affecting the intraoperative and postoperative outcomes of endoscopic treatment of BPH. However, with the rapid development of endoscopic instruments and surgical techniques, the size of the prostate tends to have a lesser influence on the outcome of endoscopic BPH treatment. Currently, MS is becoming an increasingly common disease, which in most cases predicts a poor prognosis for treatment of patients with LUTS.
Downloads
References
Anson, K., Nawrocki, J., Buckley, J., Fowler, C., Kirby, R., Lawrence, W., ... & Watson, G. (1995). A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology, 46(3), 305-310. https://doi.org/10.1016/S0090-4295(99)80211-8
Armitage, J. N., Sibanda, N., Cathcart, P. J., Emberton, M., & van der Meulen, J. H. (2007). Mortality in men admitted to hospital with acute urinary retention: database analysis. Bmj, 335(7631), 1199-1202.
Calogero, A. E., Burgio, G., Condorelli, R. A., Cannarella, R., & La Vignera, S. (2019). Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. The Aging Male, 22(1), 12-19.
Carson III, C., & Rittmaster, R. (2003). The role of dihydrotestosterone in benign prostatic hyperplasia. Urology, 61(4), 2-7. https://doi.org/10.1016/S0090-4295(03)00045-1
Chew, G. T., Gan, S. K., & Watts, G. F. (2006). Revisiting the metabolic syndrome. Medical journal of Australia, 185(8), 445-449.
De Nunzio, C., Brassetti, A., Proietti, F., Deroma, M., Esperto, F., & Tubaro, A. (2018). Metabolic syndrome and smoking are associated with an increased risk of nocturia in male patients with benign prostatic enlargement. Prostate cancer and prostatic diseases, 21(2), 287-292.
Elzayat, E. A., & Elhilali, M. M. (2007). Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. european urology, 52(5), 1465-1472. https://doi.org/10.1016/j.eururo.2007.04.074
Farnham, S. B., Webster, T. M., Herrell, S. D., & Smith Jr, J. A. (2006). Intraoperative blood loss and transfusion requirements for robotic-assisted radical prostatectomy versus radical retropubic prostatectomy. Urology, 67(2), 360-363. https://doi.org/10.1016/j.urology.2005.08.029
Gacci, M., Corona, G., Vignozzi, L., Salvi, M., Serni, S., De Nunzio, C., ... & Maggi, M. (2015). Metabolic syndrome and benign prostatic enlargement: a systematic review and meta?analysis. BJU international, 115(1), 24-31.
Gilling, P. J., Aho, T. F., Frampton, C. M., King, C. J., & Fraundorfer, M. R. (2008). Holmium laser enucleation of the prostate: results at 6 years. European urology, 53(4), 744-749. https://doi.org/10.1016/j.eururo.2007.04.052
Gupta, A., & Gupta, V. (2010). Metabolic syndrome: what are the risks for humans?. Bioscience trends, 4(5).
Jeong, I. G., Hwang, S. S., Kim, H. K., Ahn, H., & Kim, C. S. (2010). The association of metabolic syndrome and its components with serum prostate-specific antigen levels in a Korean-screened population. Cancer Epidemiology and Prevention Biomarkers, 19(2), 371-380.
Kupelian, V., McVary, K. T., Kaplan, S. A., Hall, S. A., Link, C. L., Aiyer, L. P., ... & McKinlay, J. B. (2009). Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey. The Journal of urology, 182(2), 616-625.
Laraeni, Y., Danuyanti, I. G. A. N., Resnhaleksmana, E., Pauzi, I., Mataram, I. K. A., & Agustini, N. P. (2021). High antioxidant level in cajanus sajan reduces blood glucose level and improves blood lipid profile of rats as diabetes mellitus models. International Journal of Health Sciences, 5(1), 29-37. https://doi.org/10.29332/ijhs.v5n1.725
Lodde, M., Lusuardi, L., Palermo, S., Signorello, D., Maier, K., Hohenfellner, R., & Pycha, A. (2003). En bloc transurethral resection of bladder tumors: use and limits. Urology, 62(6), 1089-1091. https://doi.org/10.1016/S0090-4295(03)00761-1
Lombard, L., Augustyn, M. N., & Ascott-Evans, B. H. (2002). The metabolic syndrome pathogenesis, clinical features and management. Cardiovascular Journal of South Africa, 13(4), 181-186.
Moon, Y. S., Kim, D. H., & Song, D. K. (2004). Serum tumor necrosis factor-? levels and components of the metabolic syndrome in obese adolescents. Metabolism, 53(7), 863-867. https://doi.org/10.1016/j.metabol.2004.02.007
Parekh, N., Lin, Y., Marcella, S., Kant, A. K., & Lu-Yao, G. (2008). Associations of lifestyle and physiologic factors with prostate-specific antigen concentrations: evidence from the National Health and Nutrition Examination Survey (2001-2004). Cancer Epidemiology and Prevention Biomarkers, 17(9), 2467-2472.
Sebastianelli, A., & Gacci, M. (2018). Current status of the relationship between metabolic syndrome and lower urinary tract symptoms. European urology focus, 4(1), 25-27.
Shir, Y., Raja, S. N., Frank, S. M., & Brendler, C. B. (1995). Intraoperative blood loss during radical retropubic prostatectomy: epidural versus general anesthesia. Urology, 45(6), 993-999. https://doi.org/10.1016/S0090-4295(99)80120-4
Sivaprakasapillai, B., Edirisinghe, I., Randolph, J., Steinberg, F., & Kappagoda, T. (2009). Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism, 58(12), 1743-1746. https://doi.org/10.1016/j.metabol.2009.05.030
Sulaeman, R., Muhasidah, .-., Purnamawati, D., Zulkifli, .-., Jafar, S. R., & Suiraoka, I. P. (2018). Progressive muscle relaxation using video aids reduces blood pressure of hypertension patients. International Journal of Health Sciences, 2(3), 33-42. https://doi.org/10.29332/ijhs.v2n3.214
Unnikrishnan, R., Almassi, N., & Fareed, K. (2017). Benign prostatic hyperplasia: Evaluation and medical management in primary care. Cleveland Clinic journal of medicine, 84(1), 53-64.
Wilson, J. D. (1980). The pathogenesis of benign prostatic hyperplasia. The American journal of medicine, 68(5), 745-756. https://doi.org/10.1016/0002-9343(80)90267-3
Xu, H., Fu, S., Chen, Y., Chen, Q., Gu, M., & Wang, Z. (2016). Smoking habits and benign prostatic hyperplasia: a systematic review and meta-analysis of observational studies. Medicine, 95(32).
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health & medical sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health & Medical Sciences (IJHMS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHMS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHMS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
